Suchergebnisse - "Ray, Avik"

PubPharm (68)

1

Comparison of Glycated Hemoglobin (HbA1c) Values Estimated by High-Performance Liquid Chromatography and Spectrophotometry : A Pilot Study

enthalten in: Cureus | 2024

von Ray, A. | Atal, S. | Sharma, S. | +1

2

Comparative effectiveness and safety of prasugrel and ticagrelor in patients of acute coronary syndrome undergoing percutaneous transluminal coronary angioplasty : A propensity score-matched analysis

enthalten in: Indian heart journal | 2024

von Ray, A. | Najmi, A. | Khandelwal, G. | +2

3

Usefulness of the PRECISE-DAPT score at differentiating between ticagrelor and prasugrel for dual antiplatelet therapy initiation

enthalten in: Journal of thrombosis and thrombolysis | 2023

von Ray, A. | Najmi, A. | Khandelwal, G. | +2

4

Retatrutide : a triple incretin receptor agonist for obesity management

enthalten in: Expert opinion on investigational drugs | 2023

von Ray, A.

5

Usefulness of the PRECISE-DAPT score at differentiating between ticagrelor and prasugrel for dual antiplatelet therapy initiation

enthalten in: Journal of thrombosis and thrombolysis | 2023

von Ray, A. | Najmi, A. | Khandelwal, G. | +2

6

Comprehensive Pharmacist-led Transitions-of-care Medication Management around Hospital Discharge Adds Modest Cost Relative to Usual Care : Time-and-Motion Cost Analysis

enthalten in: Inquiry : a journal of medical care organization, provision and financing | 2023

von Nuckols, T. | Berdahl, C. | Henreid, A. | +14

7

Letter : potential selection bias in the real-world comparison of ustekinumab versus vedolizumab as a second-line treatment for Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Adomi, M. | Ray, A.

CommentOn: Aliment Pharmacol Ther. 2022 Apr;55(7):856-866. - PMID 34935160

8

Letter : potential selection bias in the real‐world comparison of ustekinumab versus vedolizumab as a second‐line treatment for Crohn’s disease

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Adomi, M. | Ray, A.

9

Carbovigilance : curtailing the global pharmaceutical carbon footprint

enthalten in: Future healthcare journal | 2021

von Ray, A. | Sharma, S. | Sadasivam, B.

10

COVID-19 and thrombotic complications-the role of anticoagulants, antiplatelets and thrombolytics

enthalten in: Journal of family medicine and primary care | 2021

von Khandelwal, G. | Ray, A. | Sethi, S. | +3

1
2
3
4
5
6
7
Nächster »
[7]